INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE
The present invention relates to compounds that are useful as protease inhibitors, particularly as serine protease inhibitors, and more particularl y as hepatitis C NS3 protease inhibitors. As such, they act by interfering wit h the life cycle of the hepatitis C virus and are also useful as antivira...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | O'MALLEY, ETHAN PERNI, ROBERT COURT, JOHN BHISETTI, GOVINDA RAO |
| description | The present invention relates to compounds that are useful as protease inhibitors, particularly as serine protease inhibitors, and more particularl y as hepatitis C NS3 protease inhibitors. As such, they act by interfering wit h the life cycle of the hepatitis C virus and are also useful as antiviral agents. This invention also relates to pharmaceutical compositions comprisin g these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HCV NS3 protease activity and consequently, may be advantageously used as therapeutic agents against the hepatitis C virus and other viruses that are dependent upon a serine protease for proliferation. This invention also relates to methods fo r inhibiting the activity of proteases, including hepatitis C virus NS3 protea se and other serine proteases, using the compounds of this invention and relate d compounds. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2405043A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2405043A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2405043A13</originalsourceid><addsrcrecordid>eNrjZPD29PPwdPIM8Q8KVvB3Uwh2DfL0c1UICPIPcXUMdg3WUQhwDArxdA71cQzyiVTwcA1wDPEM8QxWcFYI8wwKDVbwCzaGq-ZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjkYmBqYGJsaOhsZEKAEATzctTg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE</title><source>esp@cenet</source><creator>O'MALLEY, ETHAN ; PERNI, ROBERT ; COURT, JOHN ; BHISETTI, GOVINDA RAO</creator><creatorcontrib>O'MALLEY, ETHAN ; PERNI, ROBERT ; COURT, JOHN ; BHISETTI, GOVINDA RAO</creatorcontrib><description>The present invention relates to compounds that are useful as protease inhibitors, particularly as serine protease inhibitors, and more particularl y as hepatitis C NS3 protease inhibitors. As such, they act by interfering wit h the life cycle of the hepatitis C virus and are also useful as antiviral agents. This invention also relates to pharmaceutical compositions comprisin g these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HCV NS3 protease activity and consequently, may be advantageously used as therapeutic agents against the hepatitis C virus and other viruses that are dependent upon a serine protease for proliferation. This invention also relates to methods fo r inhibiting the activity of proteases, including hepatitis C virus NS3 protea se and other serine proteases, using the compounds of this invention and relate d compounds.</description><edition>7</edition><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011011&DB=EPODOC&CC=CA&NR=2405043A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011011&DB=EPODOC&CC=CA&NR=2405043A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>O'MALLEY, ETHAN</creatorcontrib><creatorcontrib>PERNI, ROBERT</creatorcontrib><creatorcontrib>COURT, JOHN</creatorcontrib><creatorcontrib>BHISETTI, GOVINDA RAO</creatorcontrib><title>INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE</title><description>The present invention relates to compounds that are useful as protease inhibitors, particularly as serine protease inhibitors, and more particularl y as hepatitis C NS3 protease inhibitors. As such, they act by interfering wit h the life cycle of the hepatitis C virus and are also useful as antiviral agents. This invention also relates to pharmaceutical compositions comprisin g these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HCV NS3 protease activity and consequently, may be advantageously used as therapeutic agents against the hepatitis C virus and other viruses that are dependent upon a serine protease for proliferation. This invention also relates to methods fo r inhibiting the activity of proteases, including hepatitis C virus NS3 protea se and other serine proteases, using the compounds of this invention and relate d compounds.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPD29PPwdPIM8Q8KVvB3Uwh2DfL0c1UICPIPcXUMdg3WUQhwDArxdA71cQzyiVTwcA1wDPEM8QxWcFYI8wwKDVbwCzaGq-ZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjkYmBqYGJsaOhsZEKAEATzctTg</recordid><startdate>20011011</startdate><enddate>20011011</enddate><creator>O'MALLEY, ETHAN</creator><creator>PERNI, ROBERT</creator><creator>COURT, JOHN</creator><creator>BHISETTI, GOVINDA RAO</creator><scope>EVB</scope></search><sort><creationdate>20011011</creationdate><title>INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE</title><author>O'MALLEY, ETHAN ; PERNI, ROBERT ; COURT, JOHN ; BHISETTI, GOVINDA RAO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2405043A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2001</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>O'MALLEY, ETHAN</creatorcontrib><creatorcontrib>PERNI, ROBERT</creatorcontrib><creatorcontrib>COURT, JOHN</creatorcontrib><creatorcontrib>BHISETTI, GOVINDA RAO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>O'MALLEY, ETHAN</au><au>PERNI, ROBERT</au><au>COURT, JOHN</au><au>BHISETTI, GOVINDA RAO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE</title><date>2001-10-11</date><risdate>2001</risdate><abstract>The present invention relates to compounds that are useful as protease inhibitors, particularly as serine protease inhibitors, and more particularl y as hepatitis C NS3 protease inhibitors. As such, they act by interfering wit h the life cycle of the hepatitis C virus and are also useful as antiviral agents. This invention also relates to pharmaceutical compositions comprisin g these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HCV NS3 protease activity and consequently, may be advantageously used as therapeutic agents against the hepatitis C virus and other viruses that are dependent upon a serine protease for proliferation. This invention also relates to methods fo r inhibiting the activity of proteases, including hepatitis C virus NS3 protea se and other serine proteases, using the compounds of this invention and relate d compounds.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2405043A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T21%3A49%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=O'MALLEY,%20ETHAN&rft.date=2001-10-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2405043A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |